180 Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-462
| Closed | -$224K | – | 438 |
|
|
2025
Q1 | $224K | Buy |
+462
| New | +$224K | 0.04% | 359 |
|
|
2024
Q4 | – | Sell |
-912
| Closed | -$424K | – | 467 |
|
|
2024
Q3 | $424K | Sell |
912
-45
| -5% | -$20.9K | 0.07% | 255 |
|
|
2024
Q2 | $471K | Sell |
957
-19
| -2% | -$9.35K | 0.08% | 229 |
|
|
2024
Q1 | $408K | Buy |
976
+293
| +43% | +$122K | 0.07% | 236 |
|
|
2023
Q4 | $281K | Hold |
683
| – | – | 0.06% | 294 |
|
|
2023
Q3 | $237K | Buy |
683
+2
| +0.3% | +$695 | 0.05% | 299 |
|
|
2023
Q2 | $237K | Sell |
681
-101
| -13% | -$35.1K | 0.05% | 300 |
|
|
2023
Q1 | $246K | Buy |
782
+87
| +13% | +$27.4K | 0.06% | 299 |
|
|
2022
Q4 | $223K | Buy |
+695
| New | +$223K | 0.05% | 319 |
|
|
2022
Q3 | – | Sell |
-727
| Closed | -$209K | – | 388 |
|
|
2022
Q2 | $209K | Sell |
727
-302
| -29% | -$86.8K | 0.05% | 329 |
|
|
2022
Q1 | $291K | Sell |
1,029
-45
| -4% | -$12.7K | 0.06% | 283 |
|
|
2021
Q4 | $245K | Sell |
1,074
-222
| -17% | -$50.6K | 0.06% | 306 |
|
|
2021
Q3 | $236K | Buy |
1,296
+10
| +0.8% | +$1.82K | 0.05% | 328 |
|
|
2021
Q2 | $253K | Buy |
1,286
+33
| +3% | +$6.49K | 0.06% | 306 |
|
|
2021
Q1 | $267K | Buy |
1,253
+13
| +1% | +$2.77K | 0.07% | 285 |
|
|
2020
Q4 | $288K | Buy |
1,240
+184
| +17% | +$42.7K | 0.08% | 233 |
|
|
2020
Q3 | $227K | Buy |
1,056
+367
| +53% | +$78.9K | 0.09% | 230 |
|
|
2020
Q2 | $203K | Buy |
+689
| New | +$203K | 0.08% | 248 |
|